Treatment of cutaneous T cell lymphoma
22 Sep 2016
Treatment of cutaneous T cell lymphoma
Skin cancer lesions arising in uncommon regions
Developments in checkpoint immunotherapy
Targetted medicine to reduce melanoma mutational burden
Checkpoint inhibitor therapy for treating melanoma
Tumour heterogeneity and the impact on patient care
Drug repurposing in review
Tumour metabolism in chemoprevention
Bring patient voices into research
Patient advocacy in breast cancer research
Food, diet and prostate cancer
Chemoprevention of breast cancer recurrence